Showing results (151-160 of 181) with videos related to

Sort By:
Pageof 19
Molecular Oncology|October 27, 2020
SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysisLiang Liu, Tamjeed Ahmed, William J Petty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid LeukemiaTimothy S Pardee, Rebecca G Anderson, Kristin M Pladna, et al.
Cancer Research|July 5, 2002
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsivenessEna Wang, Lance D Miller, Galen A Ohnmacht, et al.
Cancer Medicine|April 30, 2019
Dissecting intratumoral myeloid cell plasticity by single cell RNA-seqQianqian Song, Gregory A Hawkins, Leonard Wudel, et al.
Neuro-Oncology Advances|February 15, 2023
Collagen deposition within brain metastases is associated with leptomeningeal failure after cavity-directed radiosurgeryMohammed Abdulhaleem, Jimmy Ruiz, Stacey O'Neill, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2016
APOL1 Renal-Risk Variants Induce Mitochondrial DysfunctionLijun Ma, Jeff W Chou, James A Snipes, et al.
Genome Biology|September 4, 2004
Discovery of estrogen receptor alpha target genes and response elements in breast tumor cellsChin-Yo Lin, Anders Ström, Vinsensius Berlian Vega, et al.
Cancer Research|September 9, 2024
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung CancerMargaret R Smith, Caroline B Dixon, Yuezhu Wang, et al.
Frontiers in Oncology|December 27, 2021
Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor OutcomesAshok K Pullikuth, Eric D Routh, Kip D Zimmerman, et al.
Pageof 19